Novel antibody for cancer therapy [ 2019 - ]

Research Grant

Researchers: Prof Andrew Scott (Principal investigator) ,  A/Pr Hui Gan ,  Prof John Mariadason ,  Prof Pramod Srivastava ,  Prof Robin Anderson

Brief description This project aims to develop a novel monoclonal antibody that has specifically targets advanced and metastatic breast cancer, enabling delivery of potent drugs into cancer cells, and inhibition of abnormal tumour cell growth.

Funding Amount $985,528.00

Funding Scheme Development Grants

Notes Development Grant